Certification for two in-vitro diagnostic (IVD) products - the CupiKIT HIV 1&2 Antibody Test Kit and the CupiKIT Hepatitis B Surface Antigen (HBsAg) Test Kit.

The history of the hepatitis B vaccine has been marked by controversies, from the ‘Australia antigen’ to the ‘Pediatric ...

Cupid Limited, (BSE - 530843, NSE - CUPID), a diversified Indian healthcare and consumer products company with a growing focus on in-vitro diagnostics (IVD),wellness, and personal care, announced that ...

Switching to a long-acting cabotegravir/rilpivirine antiretroviral regimen may be safe for patients with HIV who have prior hepatitis B virus exposure, a real-world study shows.

Huahui Health has won the first approval in China for a drug to treat chronic infections with hepatitis D virus (HDV), ...

Stocks like Larsen & Toubro, Lodha Developers, NSDL, LT Foods, eClerx Services, SBI Cards and Payment Services, GPT ...

Huahui Health announced that China National Medical Products Administration (NMPA) has granted conditional approval ...

TG Therapeutics, Inc. (NASDAQ: TGTX), today announced the upcoming schedule of presentations highlighting BRIUMVI ® (ublituximab-xiiy), to be presented (ACTRIMS) annual forum, being held February 5 – ...

Background and aims The rate of functional cure (HBsAg loss) remains unsatisfactory following pegylated interferon (PEG-IFN) treatment in chronic hepatitis B. To optimize PEG-IFN administration, this ...

Two key factors have enabled the development of the hepatitis B virus (HBV) vaccine (as reviewed in ref 1.): (1) identification of an immunogenic HBV protein that would stimulate the human immune ...

Drexel practices a No Harm Test-Optional review for fall entry. This means, with some exceptions, applicants can choose whether to include standardized test scores as part of their application to the ...

DelveInsight's Chronic Hepatitis D Market Insights report includes a comprehensive understanding of current treatment ...